News
June 2023 - Coagulo to present data on the use of the POC Testing System for the detection of apixaban in patients with intracranial hemorrhage receiving treatment with andexanet alfa (ISTH 2023).
April 2023 - Case report published with Mass General Brigham on the use of Coagulo’s POC testing to monitor argotraban treatment in a patient with antiphospholipid syndrome, HIT, and COVID-19 pneumonia (Crit Care Explor, 2023).
October 2022 - Publication on the of Coagulo’s technology to detect anticoagulation resistance and prediction of thrombotic events in pediatric patients requiring ECMO treatment with Texas Children’s Hospital (Crit Care Explor, 2022).
November 2022 - Coagulo is awarded a multi-million dollar contract with the Department of Defense for the development of a ruggedized coagulation testing system to be used in austere conditions.
October 2021 - Massachusetts General Hospital is invited to present clinical data on the use of Coagulo’s technology for complex anticoagulant management at the 2022 Society of Critical Care Medicine Congress.
October 2021 - Coagulo is invited to present abstracts on the use of our coagulation test on hospitalized patients with COVID-19 at the 2022 Society of Critical Care Medicine Congress.
September 2021 - Coagulo is invited to present results on the use of our new technology on anticoagulation assessment in hospitalized patients with COVID-19 at the 2021 American Heart Association Conference.
September 2021 - Coagulo’s CSO, Dr. Frydman, is invited to give a faculty lecture at the 2021 American Heart Association Conference on COVID-19 and Coagulation.
July 2021 - Baylor College of Medicine presents clinical data on the use of Coagulo’s technology in a pediatric ECMO population (ISTH 2021)
February 2021 - Coagulo’s CSO, Dr. Frydman, is invited to give a lecture at the North American Thrombosis Forum on Mechanisms and Histopathology of Thrombosis in COVID-19 (https://natfonline.org/events/covid-thrombosis-research-steering-storm-full-sails/)
December 2020 - Coagulo announces $6.5M financing. (https://www.businesswire.com/news/home/20201222005291/en/Coagulo-Medical-Technologies-Announces-6.5-Million-in-Financing-to-Accelerate-Delivery-of-Disruptive-Coagulation-Diagnostics-Platform)
October 2020 - Coagulo is a finalist in the American College of Emergency Physicians (ACEP) Medical Device competition.
October 2020 - Coagulo publishes article on the potential use of anticoagulants as multi-modal therapeutics for COVID-19. (Frydman GH et al, TH Open 2020;4:e288-299)
August 2020 - Coagulo has been awarded an NSF SBIR grant for the “Development of a rapid, point-of-care coagulation test for the investigation and treatment of COVID-19-related coagulopathy”
July 2020 - Coagulo’s CSO, Dr. Frydman, publishes review on COVID-19 and coagulopathy risk through her work at MIT and MGH in Clinical and Applied Thrombosis/Hemostasis (Frydman GH et al, CATH 2020;26:1-8)
June 2020 - Coagulo, in collaboration with Baylor College of Medicine and Texas Children’s Hospital, presents data on monitoring of anticoagulation in a pediatric ECMO population at the ISTH 2020 conference.
December 2019 - Coagulo wins “Favorite Product” at Massachusetts Innovation Nights.
September 2019 – Coagulo announced as Winners of the Alexandria LaunchLabs Innovation Prize - $100,000 prize and one year of lab space at LaunchLabs in Kendal Square.
August 2019 – Publication of Coagulo Technology. A New Test for the Detection of Direct Oral Anticoagulants (rivaroxaban and apixaban) in the Emergency Room Setting. CCE.
February 2019 – Dr. Frydman is selected, amongst 12 other women leaders, to join the 2019 Springboard LifeScience Cohort.
July 2018 — 64th Annual ISTH Meeting awards Dr. Frydman with Top Abstract and Young Investigator Awards for presentation on DOAC detection and identification in the Emergency Room.
June 2018 - Johns Hopkins University presentation by Dr. Frydman during Hematology Grand Rounds at Division of Hematology and Oncology.
April 2018 — Deshpande Center coverage of Coagulo’s presentation at MIT VMS Demo Day.
April 2018 — Deshpande Center profile on Coagulo’s blood diagnostics and drug monitoring technology.
February 2018 — 47th Annual Critical Care Congress abstract for Coagulo’s Research Snapshot Theater presentation.
January 2018 — Glimpse Podcast interview with Coagulo Founder and CSO.
October 2017 — MIT News coverage of Coagulo’s grant from the MIT Desphpande Center for Technological Innovation.
August 2016 — MGH Dept. of Surgery coverage of Coagulo’s grant for ‘Bedside Coagulation Testing of Coagulation Biomarkers’.